loader
Please Wait
Applying Filters...

EuroAPI Header EuroAPI Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_1999_051___rev_03 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Gedeon Richter

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    PharmaCompass

    With Fermion, start the journey of your innovative API.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 GEDEON RICHTER PLC Budapest HU (1)

    filter

    01 Lisinopril dihydrate (1)

    filter

    01 Hungary (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    GEDEON RICHTER PLC Budapest HU

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag Hungary
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Lisinopril dihydrate

      PDF Supplier PDF
      URL Supplier Web Content
      R1-CEP 1999-051 - Rev 03
      Withdrawn by Holder
      Chemical
      2011-03-23
      2015-04-16
      1120
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Certificates of Suitability (CEPs) for R1-CEP 1999-051 - Rev 03 of Gedeon Richter Plc Budapest Hu

      Looking for Certificates of Suitability (CEPs) for R1-CEP 1999-051 - Rev 03 of Gedeon Richter Plc Budapest Hu 1

      20

      Gedeon Richter Plc Budapest Hu, based in Hungary, is a pharmaceutical company.

      One of their significant offerings is Lisinopril dihydrate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1999-051 - Rev 03

      This Chemical Type CEP, issued on March 23, 2011, remains in force until April 16, 2015, ensuring its reliability within the pharmaceutical industry.

      Substance Number 1120 associated with this CEP further emphasizes

      Post Enquiry
      POST ENQUIRY